SE7712218L - Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner - Google Patents

Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner

Info

Publication number
SE7712218L
SE7712218L SE7712218A SE7712218A SE7712218L SE 7712218 L SE7712218 L SE 7712218L SE 7712218 A SE7712218 A SE 7712218A SE 7712218 A SE7712218 A SE 7712218A SE 7712218 L SE7712218 L SE 7712218L
Authority
SE
Sweden
Prior art keywords
aryloctahydro
pyrindines
procedure
preparation
Prior art date
Application number
SE7712218A
Other languages
English (en)
Inventor
D M Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7712218L publication Critical patent/SE7712218L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757—Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SE7712218A 1976-11-02 1977-10-28 Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner SE7712218L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
SE7712218L true SE7712218L (sv) 1978-05-03

Family

ID=24965981

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7712218A SE7712218L (sv) 1976-11-02 1977-10-28 Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE8103106A SE8103106L (sv) 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner
SE8103107A SE8103107L (sv) 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8103106A SE8103106L (sv) 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner
SE8103107A SE8103107L (sv) 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner

Country Status (26)

Country Link
JP (1) JPS5356669A (sv)
AR (1) AR223454A1 (sv)
AT (1) ATA782177A (sv)
AU (1) AU513679B2 (sv)
BE (1) BE860314A (sv)
CA (1) CA1100136A (sv)
CS (1) CS211380B2 (sv)
DD (1) DD133795A5 (sv)
DE (1) DE2748466A1 (sv)
DK (1) DK485277A (sv)
ES (3) ES463784A1 (sv)
FR (1) FR2369267A1 (sv)
GB (1) GB1590155A (sv)
GR (1) GR70053B (sv)
HU (1) HU176231B (sv)
IE (1) IE45901B1 (sv)
IL (1) IL53236A0 (sv)
NL (1) NL7712053A (sv)
NZ (1) NZ185539A (sv)
PH (1) PH12590A (sv)
PL (3) PL109690B1 (sv)
PT (1) PT67194B (sv)
RO (3) RO77935A (sv)
SE (3) SE7712218L (sv)
SU (3) SU812174A3 (sv)
ZA (1) ZA776497B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG30927A3 (en) * 1977-12-27 1981-09-15 Eli Lilly And Company Method for obtaining of trans- 4- alpha- phenyl- octahydro- 1h- 2- pyridine
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
ZA9510829B (en) * 1994-12-23 1996-07-03 Smithkline Beecham Corp 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
EP3056495A1 (en) 2011-02-02 2016-08-17 Vertex Pharmaceuticals Inc. Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
WO2012112743A1 (en) 2011-02-18 2012-08-23 Vertex Pharmaceuticals Incorporated Chroman - spirocyclic piperidine amides as modulators of ion channels
JP6088443B2 (ja) 2011-03-14 2017-03-01 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ イオンチャネルのモジュレーターとしてのモルホリン−スピロ環式ピペリジンアミド

Also Published As

Publication number Publication date
FR2369267B1 (sv) 1980-05-16
GR70053B (sv) 1982-07-26
DE2748466A1 (de) 1978-05-03
SU913941A3 (en) 1982-03-15
ATA782177A (de) 1981-10-15
BE860314A (fr) 1978-04-28
RO78300A (ro) 1982-04-12
IE45901B1 (en) 1982-12-29
NZ185539A (en) 1979-12-11
PL108610B1 (en) 1980-04-30
NL7712053A (nl) 1978-05-05
AU513679B2 (en) 1980-12-18
IL53236A0 (en) 1977-12-30
JPS5356669A (en) 1978-05-23
SU845777A3 (ru) 1981-07-07
PT67194B (en) 1979-03-23
GB1590155A (en) 1981-05-28
DD133795A5 (de) 1979-01-24
PL201885A1 (pl) 1978-12-04
CS211380B2 (en) 1982-02-26
ES463783A1 (es) 1979-07-16
RO77935A (ro) 1981-12-25
SE8103107L (sv) 1981-05-18
IE45901L (en) 1978-05-02
PL109690B1 (en) 1980-06-30
PT67194A (en) 1977-11-01
RO72900A (ro) 1981-11-04
PL108466B1 (en) 1980-04-30
AU3023577A (en) 1979-05-10
AR223454A1 (es) 1981-08-31
SE8103106L (sv) 1981-05-18
SU812174A3 (ru) 1981-03-07
ES463784A1 (es) 1978-06-16
CA1100136A (en) 1981-04-28
HU176231B (en) 1981-01-28
FR2369267A1 (fr) 1978-05-26
ES472276A1 (es) 1979-10-01
ZA776497B (en) 1979-06-27
PH12590A (en) 1979-06-27
DK485277A (da) 1978-05-03

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
SE427838B (sv) Forfarande for framstellning av aromatiska uretaner
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE399252B (sv) Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7704311L (sv) Forfarande for framstellning av bis-penicillanoyloxi-alkaner
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE7705447L (sv) Forfarande for framstellning av tioetrar
SE443143B (sv) Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner